What is the normal cardiac output in infants at various ages during the first year of life?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cardiac Output in Infants During Development

Cardiac output in healthy infants increases linearly with growth from approximately 0.3-0.5 L/min at birth to 1.0-1.5 L/min by 12 months of age, while cardiac index (normalized to body surface area) rises from 2.6 L/min/m² in infants under 2 months to 3.2 L/min/m² by 12 months.

Age-Specific Cardiac Output Values

Neonatal Period (First Week)

  • Absolute cardiac output: Ranges from approximately 0.3-0.8 L/min depending on birth weight 1
  • Weight-normalized output: 249 ± 34 mL/min/kg (mean ± SD) 1
    • Premature infants (<1,500g): 265 ± 32 mL/min/kg
    • Low birth weight (1,500-2,500g): 253 ± 34 mL/min/kg
    • Term infants (>2,500g): 241 ± 33 mL/min/kg
  • Clinical reference limits: Upper limit 325 mL/min/kg, lower limit 200 mL/min/kg 1

First Year of Life

Cardiac output increases linearly with height: Cardiac output (L/min) = 0.3 × height (cm) - 0.99 2

Cardiac index progression 2:

  • <2 months: 2.6 ± 0.7 L/min/m²
  • 12 months: 3.2 ± 0.7 L/min/m²

Stroke volume index progression 2:

  • <2 months: 19 ± 5 mL/m²
  • 12 months: 25 ± 5 mL/m²

Key Physiological Patterns

Linear Growth Relationship

The most robust finding is that cardiac output changes linearly with body size during infancy 2. This validates the use of cardiac index (normalized to body surface area) as the standard method for comparing cardiac output across different-sized infants up to 10-13 months of age.

Developmental Trajectory

Younger infants (<2 months) have significantly lower cardiac indexes and stroke volume indexes compared to older infants (12 months), reflecting the cardiovascular maturation that occurs during the first year 2. This increase represents both structural cardiac growth and improved myocardial contractility.

Individual Variability

Important caveat: While population-based norms exist, individual infants show considerable variation in cardiac output over time, suggesting that non-morphometric factors (such as metabolic demand, activity state, and autonomic tone) significantly modulate cardiovascular function 2. Serial measurements in the same infant may vary substantially.

Clinical Context: Heart Rate Considerations

Since cardiac output = stroke volume × heart rate, understanding normal heart rate ranges is essential 3:

Normal heart rate ranges (2nd-98th percentile):

  • 0-1 days: 93-154 bpm (mean 123)
  • 1-7 days: 90-166 bpm (mean 123-129)
  • 7-30 days: 107-182 bpm (mean 149)
  • 1-3 months: 121-179 bpm (mean 150)

Upper normal limits (98th percentile) 3:

  • First week: 166 bpm
  • First month: 179 bpm
  • After 6 months: ~160 bpm

Measurement Considerations

Validated Techniques

The research evidence primarily derives from pulsed Doppler echocardiography combined with M-mode measurements of aortic root diameter 2, 1. This noninvasive approach has been validated against invasive cardiac catheterization techniques and provides reliable estimates suitable for clinical use.

Factors Affecting Measurements

Cardiac output measurements can be influenced by:

  • Metabolic state: Fever, infection, anemia increase cardiac output 3
  • Activity state: Awake vs. sleeping significantly affects heart rate 4
  • Temperature: Each 0.1°C increase in rectal temperature raises heart rate by 0.5 bpm 4
  • Transitional physiology: Major hemodynamic changes occur in the first 8-12 hours after birth 5

Practical Application

For clinical assessment, use these benchmarks:

  1. Weight-normalized approach (birth to 1 month): Expect 200-325 mL/min/kg 1
  2. Cardiac index approach (after 1 month): Expect 2.6-3.2 L/min/m² depending on age 2
  3. Consider individual trajectory: A single measurement should be interpreted in context of the infant's growth pattern and clinical state

Red flags for abnormal cardiac output:

  • Values >30% above or below age-matched predicted values 6
  • Failure to increase cardiac output proportionally with growth
  • Persistent tachycardia (>179 bpm in first month) without clear metabolic cause 3

Related Questions

What is the normal stroke volume for infants when normalized to body weight (ml/kg) or body surface area (ml/m²)?
What is the most common cause of mortality among children under five in the developing world?
How should I conduct a 12‑month‑old well‑child visit, including the assessment components and questions to ask?
Is a blood pressure of 96/59 mm Hg normal for a 14‑year‑old adolescent?
What is the diagnosis and treatment for a 15-year-old male with acute palpitations and tachycardia (180 bpm) triggered by emotional stress, without syncope or other symptoms?
In a patient with MELAS syndrome (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) who has been newly diagnosed with diabetes, what is the best first-line diabetes medication?
How can stroke volume be estimated in an infant?
What is the normal stroke volume for infants when normalized to body weight (ml/kg) or body surface area (ml/m²)?
In a patient on lamotrigine 400 mg daily, lurasidone 80 mg daily, and buspirone 30 mg daily who is using a combined oral contraceptive that lowers lamotrigine levels, is unwilling to change the contraceptive, and appears to be rapid cycling, what is the most appropriate next step in management?
How should valproic acid be added to a patient currently taking lurasidone 80 mg daily, buspirone 30 mg daily, lamotrigine 400 mg daily, and a combined oral contraceptive, including dosing, titration, laboratory monitoring, and lamotrigine dose adjustment?
What are the recommended doses for guideline‑directed medical therapy in an adult with heart failure with reduced ejection fraction?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.